One of the biggest challenges in fighting a chronic or serious illness is wading through and understanding the thousands (or millions) of articles, posts, and research studies that can be found online. Medivizor has a solution for that problem by providing personalized health research curation based on a detailed questionnaire completed by a subscriber. On Get Social Health, I have a conversation with Medivizor CEO Tal Givoly about providing patients with research that is vetted for accuracy and relevancy. Catch our conversation or drop in at time stamps below.
00:00 Introduction
00:55 Tal Givoly, CEO of Medivizor
01:55 “Chronic web researcher”
03:49 How does the Medivizor search work?
05:04 How is relevancy determined?
07:50 Needle in the wrong haystack
08:31 Delivering any information or only currently usable information?
09:42 Midivizor is not focused on preventive or diagnosis information
12:55 Physician’s response to bad information from patients
15:10 How does the physician get copies of the information
16:30 The family physician
More Read
Tal Givoly (CEO)
Dr. Oren Fuerst (Chairman)
Prof. Steven Kaplan, MD (Chief Medical Officer)
17:08 What is the business model for Medivizor
20:35 Standard of care/treatment protocols
20:35 How many patients are in Medivizor?
21:08 Does this data reflect population health?
23:40 Who is vetting all the information?
24:41 Is there a community for Medivizor members?
26:15 #PatientChat
29:16 Why did you start Medivizor?
32:55 How many members are caregivers vs patients?
33:55 linking to content online.
34:00 Where am I going to get enough content
Putting labels and roles on people
35:25 How does social media play into Medivizor
37:20 Is your platform in English only?
37:55 What are your financial goals?
38:40 How is the information provided?
40:16 Social Media Tip: Jared Johnson – Be thankful
40:56 A special Announcement! Launching the Get Social Health Academy pilot course launch!
Visit our resources page for more valuable (and free!) resources on social media and digital health.